Disease relevance of Streptococcus milleri Group

• GTF-I and GTF-SI were expressed from two Streptococcus milleri or Escherichia coli transformants harboring gtfB or gtfC, respectively [1].
• An arginine/ornithine antiport was also found in Streptococcus faecalis DS5, Streptococcus sanguis 12, and Streptococcus milleri RH1 type 2 [2].
• Streptococcus MG-intermedius (Streptococcus milleri) septic arthritis in a patient with rheumatoid arthritis [3].
• Streptococcus pneumoniae, Streptococcus milleri and Streptococcus mitior are most susceptible to cefpodoxime, cefdinir, cefuroxime and BAY 3522 [4].
• No detectable extracellular polysaccharide was elaborated by Streptococcus milleri, Streptococcus faecalis or Streptococcus lactis [5].

High impact information on Streptococcus milleri Group

• Cells of representative strains of oral "Streptococcus milleri" firmly adhered to glass surfaces when grown in glucose broths as well as in fructose and sucrose broths [6].
• The type-specific antigen of serotype b Streptococcus milleri was extracted with trichloroacetic acid from a purified cell wall preparation of the strain NCTC 10708 and then purified on a DEAE-Sephadex A-25 column, followed by a Sephadex G-100 column [7].
• The Streptococcus milleri group are uniformly susceptible to penicillin G, but their susceptibilities to different cephalosporins vary considerably [8].
• Detection of diacetyl (caramel odor) in presumptive identification of the "Streptococcus milleri" group [9].
• The Streptococcus milleri group were shown to bind fibronectin (Fn) to their cell-surface and this binding increased the adhesion of cells to hydroxyapatite [10].

Chemical compound and disease context of Streptococcus milleri Group

• Adherence of 3H-labelled cells of Streptococcus gordonii and Streptococcus milleri to artificial pellicles prepared from saliva supplemented with glucosyltransferases from mutants streptococci was examined using a new assay for sucrose-dependent cell-to-pellicle attachment [11].
• The susceptibility of four macrolides (erythromycin, clarithromycin, roxithromycin and azithromycin) and a ketolide (telithromycin) was tested using 58 clinically isolated strains of the 'Streptococcus milleri' group (SMG) [12].
• Forty-four strains of non-haemolytic streptococci, from a variety of sites, that required CO2 for aerobic growth were identified as Streptococcus milleri [13].
• The rate of nonsusceptibility to clindamycin and penicillin among anaerobes and Streptococcus milleri group isolates increased [14].
• Antibacterial action of azithromycin against 31 strains of dental infection-derived Streptococcus milleri and tissue transfer of the agent were compared with ampicillin, the drug of first choice for dental infections [15].

Gene context of Streptococcus milleri Group

• Candida albicans and nosocomial respiratory infection-causing bacteria, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa and the Streptococcus milleri group (S. constellatus and S. intermedius), were selected as test microorganisms [16].
• Some oral anaerobes from the Streptococcus milleri strain group were found to secrete human specific hemolytic toxin, which was detected when bacteria were cultured in Todd-Hewitt broth and Brain Heart Infusion broth [17].
• Of 271 Gram-positive, catalase-negative, chain-forming cocci isolated from crevicular and supragingival plaques of 22 adults, 71 stains were clustered as Streptococcus milleri by testing 23 physiological characters [18].

References